List of Zypitamag drug patents

Zypitamag is owned by Medicure.

Zypitamag contains Pitavastatin Magnesium.

Zypitamag has a total of 1 drug patent out of which 0 drug patents have expired.

Zypitamag was authorised for market use on 14 July, 2017.

Zypitamag is available in tablet;oral dosage forms.

The generics of Zypitamag are possible to be released after 19 January, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8829186 MEDICURE Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
Jan, 2031

(7 years from now)

Drugs and Companies using PITAVASTATIN MAGNESIUM ingredient

Market Authorisation Date: 14 July, 2017

Treatment: NA


More Information on Dosage

ZYPITAMAG family patents


United States





900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in